Eukaryotic initiation factor 5a plays an essential role in luteinizing hormone receptor regulation

Molecular Endocrinology

Volumn 28, Issue 11, 2014, Pages 1796-1806

  Menon, Bindu ^a   Gulappa, Thippeswamy ^a   Menon, K M J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CHORIONIC GONADOTROPIN; INITIATION FACTOR 5A; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; INITIATION FACTOR; LUTEINIZING HORMONE; RNA; RNA BINDING PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FRACTIONATION; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING ASSAY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; ANIMAL; DOWN REGULATION; GENETICS; HUMAN; METABOLISM; OVARY; RNA STABILITY; SPRAGUE DAWLEY RAT;

ANIMALS; CHORIONIC GONADOTROPIN; DOWN-REGULATION; FEMALE; HUMANS; LUTEINIZING HORMONE; OVARY; PEPTIDE INITIATION FACTORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LH; RNA; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84908351327     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1132     Document Type: Article

References (55)

1. Dufau ML. The luteinizing hormone receptor. Annu Rev Physiol. 1998;60:461–496.
2. Rajagopalan-Gupta RM, Lamm ML, Mukherjee S, Rasenick MM, Hunzicker-Dunn M. Luteinizing hormone/choriogonadotropin receptor-mediated activation of heterotrimeric guanine nucleotide binding proteins in ovarian follicular membranes. Endocrinology. 1998;139:4547–4555.
3. Segaloff DL, Ascoli M. The lutropin/choriogonadotropin receptor… 4 years later. Endocr Rev. 1993;14:324–347.
4. Menon KMJ, Munshi UM, Clouser CL, Nair AK. Regulation of luteinizing hormone/human chorionic gonadotropin receptor expression: a perspective. Biol Reprod. 2004;70:861–866.
5. Menon KMJ, Nair AK, Wang L. A novel post-transcriptional mechanism of regulation of luteinizing hormone receptor expression by an RNA binding protein from the ovary. Mol Cell Endocrinol. 2006;246:135–141.
6. Menon KMJ, Menon B, Wang L, Gulappa T, Harada M. Molecular regulation of gonadotropin receptor expression: relationship to ste-rol metabolism. Mol Cell Endocrinol. 2010;329:26–32.
7. Segaloff DL, Wang HY, Richards JS. Hormonal regulation of lu-teinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization. Mol Endocrinol. 1990;4:1856–1865.
8. Kash JC, Menon KMJ. Sequence-specific binding of a hormonally regulated mRNA binding protein to cytidine-rich sequences in the lutropin receptor open reading frame. Biochemistry. 1999;38: 16889–16897.
9. Nair AK, Menon KMJ. Isolation and characterization of a novel trans-factor for luteinizing hormone receptor mRNA from ovary. J Biol Chem. 2004;279:14937–14944.
10. Nair AK, Kash JC, Peegel H, Menon KMJ. Post-transcriptional regulation of luteinizing hormone receptor mRNA in the ovary by a novel mRNA-binding protein. J Biol Chem. 2002;277:21468–21473.
11. Menon B, Sinden J, Menon KMJ. Association of luteinizing hormone receptor (LHR) mRNA with its binding protein leads to de-capping and degradation of the mRNA in the p bodies. Biochim Biophys Acta. 2013;1833:1173–1179.
12. Nair AK, Menon KMJ. Regulation of luteinizing hormone receptor expression: evidence of translational suppression in vitro by a hor-monally regulated mRNA-binding protein and its endogenous association with luteinizing hormone receptor mRNA in the ovary. J Biol Chem. 2005;280:42809–42816.
13. Menon B, Peegel H, Menon KMJ. Evidence for the association of luteinizing hormone receptor mRNA-binding protein with the translating ribosomes during receptor downregulation. Biochim Biophys Acta. 2009;1793:1787–1794.
14. Wang L, Gulappa T, Menon KMJ. Identification and characterization of proteins that selectively interact with the LHR mRNA binding protein (LRBP) in rat ovaries. Biochim Biophys Acta. 2010; 1803:591–597.
15. Zanelli CF, Valentini SR. Is there a role for eIF5A in translation? Amino Acids. 2007;33:351–358.
16. Ruhl M, Himmelspach M, Bahr GM, et al. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol. 1993;123:1309–1320.
17. Zuk D, Jacobson A. Asingle amino acid substitution inyeast eIF-5A results in mRNA stabilization. EMBO J. 1998;17:2914–2925.
18. Schrader R, Young C, Kozian D, Hoffmann R, Lottspeich F. Temperature-sensitive eIF5A mutant accumulates transcripts targeted to the nonsense-mediated decay pathway. J Biol Chem. 2006;281: 35336–35346.
19. Dever TE, Green R. The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb Perspect Biol. 2012;4:a013706.
20. Gutierrez E, Shin BS, Woolstenhulme CJ, et al. eIF5A promotes translation of polyproline motifs. Mol Cell. 2013;51:35–45.
21. Saini P, Eyler DE, Green R, Dever TE. Hypusine-containing protein eIF5A promotes translation elongation. Nature. 2009;459:118–121.
22. Rossi D, Galvão FC, Bellato HM, et al. eIF5A has a function in the cotranslational translocation of proteins into the ER. Amino Acids. 2014;46:645–653.
23. Park MH, Nishimura K, Zanelli CF, Valentini SR. Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids. 2010;38:491–500.
24. Park MH, Wolff EC, Folk JE. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors. 1993;4:95–104.
25. Liu YP, Nemeroff M, Yan YP, Chen KY. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA andU6snRNA requires deoxyhypusine or hypusine modification. Biol Signals. 1997;6:166–174.
26. Robbins RD, Tersey SA, Ogihara T, et al. Inhibition of deoxyhy-pusine synthase enhances islet /3 cell function and survival in the setting of endoplasmic reticulum stress and type 2 diabetes. J Biol Chem. 2010;285:39943-39952.
27. Wang L, Nair AK, Menon KMJ. Ribonucleic acid binding protein-mediated regulation of luteinizing hormone receptor expression in granulosa cells: relationship to sterol metabolism. Mol Endocrinol. 2007;21:2233-2241.
28. T method. Methods. 2001;25:402-408.
29. Wolff EC, Lee SB, Park MH. Assay of deoxyhypusine synthase activity. Methods Mol Biol. 2011;720:195-205.
30. Hoffman YM, Peegel H, Sprock MJ, Zhang QY, Menon KMJ. Evidence that human chorionic gonadotropin/luteinizing hormone receptor down-regulation involves decreased levels of receptor messenger ribonucleic acid. Endocrinology. 1991;128:388-393.
31. 125I-choriogonadotropin by membrane-associated and solubilized receptors. J Biol Chem. 1976;251:7398-7404.
32. Menon B, Sinden J, Franzo-Romain M, Botta RB, Menon KMJ. Regulation of LH receptor mRNA binding protein by miR-122 in rat ovaries. Endocrinology. 2013;154:4826-4834.
33. Menon KMJ, Nair AK, Wang L, Peegel H. Regulation of luteinizing hormone receptor mRNA expression by a specific RNA binding protein in the ovary. Mol Cell Endocrinol. 2007;260-262:109-116.
34. Wang L, Menon KMJ. Regulation of luteinizing hormone/chori-onic gonadotropin receptor messenger ribonucleic acid expression in the rat ovary: relationship to cholesterol metabolism. Endocrinology. 2005;146:423-431.
35. Zanelli CF, Maragno AL, Gregio AP, et al. eIF5A binds to transla-tional machinery components and affects translation in yeast. Biochem Biophys Res Commun. 2006;348:1358-1366.
36. Chen ZP, Yan YP, Ding QJ, et al. Effects of inhibitors of deoxyhypusine synthase on the differentiation of mouse neuroblastoma and erythroleukemia cells. Cancer Lett. 1996;105:233-239.
37. Maier B, Ogihara T, Trace AP, et al. The unique hypusine modification of eIF5A promotes islet /3 cell inflammation and dysfunction in mice. J Clin Invest. 2010;120:2156-2170.
38. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci. 1949;51:660-672.
39. Kash JC, Menon KMJ. Identification of a hormonally regulated luteinizing hormone/human chorionic gonadotropin receptor mRNA binding protein. Increased mrna binding during receptor down-regulation. J Biol Chem. 1998;273:10658-10664.
40. Facchiano AM, Stiuso P, Chiusano ML, et al. Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A). Protein Eng. 2001;14:881-890.
41. Cooper HL, Park MH, Folk JE, Safer B, Braverman R. Identification of the hypusine-containing protein hy+ as translation initiation factor eIF-4D. Proc Natl Acad Sci USA. 1983;80:1854-1857.
42. Kemper WM, Berry KW, Merrick WC. Purification and properties of rabbit reticulocyte protein synthesis initiation factors M2Ba and M2B/3.JBiol Chem. 1976;251:5551-5557.
43. Thomas A, Goumans H, Amesz H, Benne R, Voorma HO. A comparison of the initiation factors of eukaryotic protein synthesis from ribosomes and from the postribosomal supernatant. Eur J Biochem. 1979;98:329-337.
44. Kang HA, Hershey JW. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem. 1994;269:3934-3940.
45. Park MH, Wolff EC, Lee YB, Folk JE. Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J Biol Chem. 1994; 269:27827-27832.
46. Caraglia M, Marra M, Giuberti G, et al. The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apopto-sis induced by interferon-a and EGF in human cancer cells. J Biochem. 2003;133:757-765.
47. Taylor CA, Sun Z, Cliche DO, et al. Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor a signalling. Exp Cell Res. 2007;313:437-449.
48. Taylor CA, Senchyna M, Flanagan J, et al. Role of eIF5A in TNF-a-mediated apoptosis of lamina cribrosa cells. Invest Ophthalmol Vis Sci. 2004;45:3568-3576.
49. Li AL, Li HY, Jin BF, et al. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. JBiol Chem. 2004; 279:49251-49258.
50. Xu A, Chen KY. Hypusine is required for a sequence-specific interaction of eukaryotic initiation factor 5A with postsystematic evolution of ligands by exponential enrichment RNA. J Biol Chem. 2001;276:2555-2561.
51. Parker MT, Gerner EW. Polyamine-mediated post-transcriptional regulation of COX-2. Biochimie. 2002;84:815-819.
52. LaPolt PS, Oikawa M, Jia XC, Dargan C, Hsueh AJ. Gonadotropin-induced up-and down-regulation of rat ovarian LH receptor message levels during follicular growth, ovulation and luteinization. Endocrinology. 1990;126:3277-3279.
53. Gregio AP, Cano VP, Avaca JS, Valentini SR, Zanelli CF. eIF5A has a function in the elongation step of translation in yeast. Biochem Biophys Res Commun. 2009;380:785-790.
54. Rosorius O, Reichart B, Kratzer F, Heger P, Dabauvalle MC, Hau-ber J. Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: evidence for direct interaction with the export receptor CRM1. J Cell Sci. 1999;112:2369-2380.
55. Menon B, Franzo-Romain M, Damanpour S, Menon KMJ. Luteinizing hormone receptor mRNA down-regulation is mediated through ERK-dependent induction of RNA binding protein. Mol Endocrinol. 2011;25:282-290.